Clinical trial
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of…
NCT00033644 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00033644 |
|---|---|
| Title | Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus |
| Official title | A Phase II Evaluation of DMAP Plus GM-CSF in the Treatment of Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug |
| Interventions | sargramostim, cisplatin, dacarbazine, doxorubicin hydrochloride, mitomycin C |
| Start date | Mar 1, 2002 |
| Primary completion | Oct 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 11, 2013 |
| Countries | Norway, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: